2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate

We are 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS:1911578-98-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
Remdesivir Impurity 21
 
Molecular Formula:  C21H23F5NO5P
Molecular Weight: 495.37700
 
Items of Analysis Standard of Analysis Test Results
Appearance White or almost white powder Conform
Assay(HPLC) >99.0% 99.68%
Moisture ≤0.5% 0.14%
Loss on drying ≤0.5% 0.05%
Residue on ignition ≤0.10% 0.056%
Enantiomeric DR ≤0.10% 0.0060%
Diastereomer DS ≤0.1% ND
LR <0.2% ND
Conclusion Conforms to Factory Standard
 

 
 
 

2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate


Related News: However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.4-(1-naphthalenyl)-N-(1,2,3,4-tetrahydro-5-methoxy-1-naphthalenyl)-1-piperazineacetamide However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.2-Chloro-4,5-difluorobenzaldehyde CAS:165047-23-4 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.(1S,4S)-1,4-dimethyl-1,2-dihydro-6H-pyrazino[2,1-b]quinazoline-3,6(4H)-dione The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
N-(3-Aminopropyl)-N-dodecyl-1,3-propanediamine Cas:2372-82-9 View Details
(R)-(+)-2-(4-Hydroxyphenoxy)propionic acid View Details
2-Mercaptobenzimidazole View Details
2-fluoro-2-methylpropan-1-ol Cas:3109-99-7 manufacturer 5-bromo-4-methylpyridine-2-carbonitrile manufacturer Copper Chloride Basic manufacturer triethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane manufacturer 4-Biphenylboronic acid manufacturer